FDA Warns of Prostate Cancer Risk with Avodart and Proscar

submitted by: admin on 09/21/2013

The FDA is requiring that Avodart and Proscar manufacturers disclose that there is an approximately 50% increased incidence of high grade prostate cancer with their usage. It also pointed out that they are not approved for prostate cancer prevention. These drugs block the conversion of testosterone to dihydro-testosterone, which is believed to be one the causes of BPH and low grade prostate cancer.

 

 

 

 

FDA Warns of Prostate Cancer Risk with Avodart and Proscar (Video)

Part of...
Program Figures
3689 Members
7 Wellness Coaches
2639 Articles
0 Blog posts
0 Blog comments

Keywords for this Article

Why Become a Member of DoctorSaputo.com?

  • Membership is always free at DoctorSaputo.com
  • Member Assessment Results are securely archived
  • All Archived Member Data is accessible 24/7
  • Members can Track Progress over time
  • Members receive Dr. Saputo's Monthly Newsletter

 

Strategic Partners

Dr. Len's health clinic

Immune system boosting meditations and Qigong exercises